Literature DB >> 17318805

Formation of diagnostic product ions from cyanobacterial cyclic peptides by the two-bond fission mechanism using ion trap liquid chromatography/multi-stage mass spectrometry.

Tsuyoshi Mayumi1, Hajime Kato, Yoshito Kawasaki, Ken-ichi Harada.   

Abstract

Product ions obtained by tandem mass spectrometry (MS/MS) are quite effective for the amino acid sequencing of linear peptides. However, in the case of cyclic peptides, the fragmentation pattern is complicated because the cleavages occur randomly and product ions are generated as a(n), b(n), c(n), x(n), y(n) and z(n) series ions; therefore, the authors have never obtained sufficient sequence information. In order to overcome this problem, we applied ion trap liquid chromatography/multi-stage mass spectrometry (LC/MS(n)) and characterized the product ions obtained from anabaenopeptins and aeruginopeptins as the cyclic peptides. For the anabaenopeptins, MS(2) analysis did not provide sufficient sequence information on the cyclic structure, and MS(3) analysis was applied to sequence the constituent amino acids. Diagnostic product ions were obtained by the MS(3) analysis and were quite effective for obtaining the sequence information of the constituent amino acids. MS(2) analysis was, however, sufficient to obtain the sequence information of the aeruginopeptins. In both cases, the resulting product ions obtained from the cyclic structures were formed by the two-bond fission mechanism of the precursor ion, in which an initial fission of the cyclic structure to a linear one and subsequent fission(s) at the peptide bonds are included. The fragmentations were similar for the structurally related compounds, indicating that the cleavages occurred at definite peptide bonds. In addition, the resulting product ions are generated as b(n) series ions and the mass difference facilitates the amino acid sequencing. Thus, ion trap LC/MS(n) provides sequence information, and the resulting product ions are reproducible among the structurally related compounds and reliable for the sequencing of the constituent amino acids of the cyclic structure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318805     DOI: 10.1002/rcm.2920

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  6 in total

1.  mMass as a software tool for the annotation of cyclic peptide tandem mass spectra.

Authors:  Timo H J Niedermeyer; Martin Strohalm
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

2.  Structural Characterization of New Peptide Variants Produced by Cyanobacteria from the Brazilian Atlantic Coastal Forest Using Liquid Chromatography Coupled to Quadrupole Time-of-Flight Tandem Mass Spectrometry.

Authors:  Miriam Sanz; Ana Paula Dini Andreote; Marli Fatima Fiore; Felipe Augusto Dörr; Ernani Pinto
Journal:  Mar Drugs       Date:  2015-06-18       Impact factor: 5.118

3.  Cyanopeptolins with Trypsin and Chymotrypsin Inhibitory Activity from the Cyanobacterium Nostoc edaphicum CCNP1411.

Authors:  Hanna Mazur-Marzec; Anna Fidor; Marta Cegłowska; Ewa Wieczerzak; Magdalena Kropidłowska; Marie Goua; Jenny Macaskill; Christine Edwards
Journal:  Mar Drugs       Date:  2018-06-26       Impact factor: 5.118

4.  Lyngbyastatins 8-10, elastase inhibitors with cyclic depsipeptide scaffolds isolated from the marine cyanobacterium Lyngbya semiplena.

Authors:  Jason C Kwan; Kanchan Taori; Valerie J Paul; Hendrik Luesch
Journal:  Mar Drugs       Date:  2009-11-03       Impact factor: 5.118

5.  Diversity of peptides produced by Nodularia spumigena from various geographical regions.

Authors:  Hanna Mazur-Marzec; Monika J Kaczkowska; Agata Blaszczyk; Reyhan Akcaalan; Lisa Spoof; Jussi Meriluoto
Journal:  Mar Drugs       Date:  2012-12-21       Impact factor: 5.118

6.  High Levels of Anabaenopeptins Detected in a Cyanobacteria Bloom from N.E. Spanish Sau-Susqueda-El Pasteral Reservoirs System by LC-HRMS.

Authors:  Cintia Flores; Josep Caixach
Journal:  Toxins (Basel)       Date:  2020-08-22       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.